Abstract:Background Several cell-based therapies for adjunctive treatment of acute myocardial infarction have been investigated in multiple clinical trials, but the timing of transplantation remains controversial. We conducted a meta-analysis of randomized controlled trials to investigate the effects of timing on bone marrow-derived cell (BMC) therapy in acute myocardial infarction (AMI). Methods A systematic literature search of PubMed, MEDLINE, and Cochrane Evidence-Based Medicine databases from January 2000 to June 2017 was performed on randomized controlled trials with at least a 3-month follow-up for patients with AMI undergoing emergency percutaneous coronary intervention (PCI) and receiving intracoronary BMC transfer thereafter. The defined end points were left ventricular (LV) ejection fraction, LV end-diastolic and end-systolic index. The data were analyzed to evaluate the effects of timing on BMC therapy. Results Thirty-four RCTs comprising a total of 2,307 patients were included; the results show that, compared to the control group, AMI patients who received BMC transplantation showed significantly improved cardiac function. BMC transplantation 3–7 days after PCI (+3.32%; 95% CI, 1.91 to 4.74; P < 0.00001) resulted in a significant increase of left ventricular ejection fraction (LVEF). As for the inhibitory effect on ventricular remodeling, BMC transplantation 3–7 days after PCI reduced LV end-diastolic indexes (–4.48; 95% CI, −7.98 to –0.98; P = 0.01) and LV end-systolic indexes (–6.73; 95% CI, –11.27 to –2.19; P = 0.004). However, in the groups who received BMC transplantation either within 24 hours or later than 7 days there was no significant effect on treatment outcome. In subgroup analysis, the group with LVEF ≤ 50% underwent a significant decrease in LV end-diastolic index after BMC transplantation (WMD = –3.29, 95% CI, –4.49 to –2.09; P < 0.00001); the decrease was even more remarkable in the LV end-systolic index after BMC transplantation in the group with LVEF ≤ 50% (WMD = –5.25, 95% CI, –9.30 to –1.20; P = 0.01), as well as in patients who received a dose of 10^7–10^8 cells (WMD = –12.99, 95% CI, –19.07 to –6.91; P < 0.0001). In the group with a follow-up of more than 12 months, this beneficial effect was significant and increased to a more pronounced effect of +3.58% (95% CI, 1.55 to 5.61; P = 0.0006) when compared with control. Conclusions In this meta-analysis, BMC transfer at 3 to 7 days post-AMI was superior to transfer within 24 hours or more than 7 days after AMI in improving LVEF and decreasing LV end-systolic dimensions or LV end-diastolic dimensions. It is more effective in patients with lower baseline LVEF (≤50%) and the effect can last more than 12 months.

Exploration on the Effect of Predeposit Autotransfusion on Bone Marrow Hematopoiesis after Femoral Shaft Fracture.

STUDY ON THE EFFECT OF ARTIFICIAL HIP JOINT REPLACEMENT ON BLOOD VESSEL CECs, EPCs AND SERUM OSTEOCALCIN OF PATIENTS WITH TRAUMATIC OSTEONECROSIS OF THE FEMORAL HEAD

N‐acetyl‐L‐cysteine Improves Bone Marrow Endothelial Progenitor Cells in Prolonged Isolated Thrombocytopenia Patients Post Allogeneic Hematopoietic Stem Cell Transplantation

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

[Effect of donor bone marrow transfusion on renal allograft function in kidney transplant patients].

Effects of ulinastatin on activated leukocytes and platelets during intraoperative autotransfusion

The effect of transfusion on survival in head and neck cancer after free tissue reconstruction

Implementation of Patient Blood Management in Orthotopic Heart Transplants: A Single Centre Retrospective Observational Review

Predictive factors for the development of anemia after hematopoietic stem cell donation

Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients Following Hematopoietic Stem Cell Transplantation

The Effect of High Intensity Interval Exercise on Platelet Engraftment in Autologous Bone Marrow Transplantation (BMT)

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

Fractures of the femur and blood transfusions

Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation

Clinical application of a modified predeposit autologous red blood cell apheresis in multistage spinal fusion: a single-center retrospective study

Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials

Transplantation of Autologous Bone Marrow Mononuclear Cells for Patients with Lower Limb Ischemia

Effect on Left Ventricular Function of Intracoronary Transplantation of Autologous Bone Marrow Mesenchymal Stem Cell in Patients with Acute Myocardial Infarction

Clinical experiments on marrow stem cell mobilization after off-pump coronary bypass graft

Evaluation of a Blood Reserve Protocol for Hip Fracture Surgery in the Elderly

Effect of Different Methods of Blood Collecting on Concentration of Bone Marrow Mononuclear Cells